Ascorbic acid 100mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Ascorbic acid

Available from:

Crescent Pharma Ltd

ATC code:

A11GA01

INN (International Name):

Ascorbic acid

Dosage:

100mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 09060301; GTIN: 5017123037139

Patient Information leaflet

Patient Information Lea
f
l
e
t
A
S
C
O
R
B
I
C
A
C
I
D
100
M
G
T
AB
L
E
T
S
This medicine will be called Ascorbic Acid
T
a
b
l
e
t
s
in this
l
ea
f
l
e
t
.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE.
• Keep this leaflet. You may need to read it again.
• This medicine is only for you. Do not give it to
anyone else to take. It may harm them, even if
their symptoms are the same as yours.
• If you have any further questions, please ask your
doctor or pharmacist.
• If you get any side effects talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
IN
THIS
L
E
A
FL
E
T
:
1. What Ascorbic Acid Tablets are and what they a
r
e
used
f
o
r
2. Before you take Ascorbic Acid
T
a
b
l
e
t
s
3. How to take Ascorbic Acid
T
a
b
l
e
t
s
4. Possible side e
ff
e
c
t
s
5. How to store Ascorbic Acid
T
a
b
l
e
t
s
6. Further
i
n
f
o
rm
a
t
io
n
1. WHAT ASCORBIC ACID
TABLETS
ARE
A
ND
WHAT THEY ARE USED
F
O
R
These tablets contain the active ingredient, a
s
c
o
r
b
i
c
acid. Ascorbic acid is the chemical name for
V
i
t
a
m
i
n
C. The tablets can be used to increase the amount
o
f
Vitamin C in the
d
i
e
t
.
Vitamin C Tablets are used to treat patients
wi
t
h
scurvy or they can be used by people who are at
r
i
s
k
of Vitamin C
d
e
f
i
c
i
e
n
c
y
.
2. BEFORE YOU TAKE ASCORBIC ACID
TA
B
LE
T
S
SOME
PEOPLE
MUST NOT
TAKE THESE
T
A
B
L
E
T
S.
DO
NOT TAKE THESE TABLETS
IF
:
•
You know you are allergic to ascorbic acid or to any
of the other ingredients
(
t
h
e
s
e are listed in Section 6
)
•
You suffer from hyperoxaluria
(
e
x
c
e
ss
oxalic acid
i
n
the
ur
i
n
e
)
.
YOU
MUST
BE
ESPECIALLY CAREFUL
IF
:
•
You are pregnant or
b
r
ea
s
t
f
ee
d
i
n
g
.
•
You have an intolerance to some sugars.
T
h
e
s
e
tablets contain lactose and
su
c
r
o
s
e.
If any of the conditions above apply to you,
p
l
ea
s
e
discuss your treatment with your doctor before
t
a
ki
n
g
this
m
e
d
i
c
i
n
e.
TAKING OTHER
M
E
DICINES
Ascorbic Acid Tablets can affect some
o
t

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid Tablets BP 100 mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100.0 mg of ascorbic acid.
3
PHARMACEUTICAL FORM
Tablet.
Ascorbic Acid Tablets BP 100 mg are presented as white to off-white
normal
convex tablets engraved with company logo on one side and A010 on the
other
side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Prevention and treatment of scurvy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults and children over 6 years:
Prophylactic: 25 - 75 mg daily.
Note: this unit dosage form is unsuitable for prophylactic use.
Therapeutic: not less than 250 mg daily in divided doses.
Children under 6 years:
This unit dosage form is unsuitable for children under 6 years.
Elderly:
Dosage same as for adults.
Route of administration
Oral.
4.3
CONTRAINDICATIONS
Hypersensitivity to ascorbic acid or to any of the excipients.
Hyperoxaluria.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Excessive use of chewable ascorbic acid tablets may cause breakdown of
enamel and
increased incidence of caries.
Increased intake of ascorbic acid over a prolonged period may result
in an increase in
renal clearance of ascorbic acid and deficiency may result if it is
withdrawn rapidly.
Large doses are associated with the formation of renal calcium oxalate
calculi.
The administration of therapeutic doses of ascorbic acid may interfere
with Clinistix
test for glucosuria giving a false negative result.
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Concurrent use of ascorbic acid with barbiturates or primidone may
increase the
urinary excretion of ascorbic acid.
Concurrent use with cellulose sodium phosphate may result in
metabolism of ascorbic
acid to oxalate.
Concurrent use of desferrioxamine with ascorbic acid enhances tissue
iron toxicity
especially
in
the
heart.
Concurrent
administration
of
ascorbic
acid
with
desferrioxamine
enhances
urinary
iron
excretion.
Cases
of
cardiomyopathy
and
congestive
heart
failur